NCT03978481|Completed
Loading search results
Sponsor study identifier
observational
3,700
1 country
1
Study Start
January 30, 2019
Actual (reported)Primary Completion
January 30, 2020
Actual (reported)Study Completion
April 30, 2020
Actual (reported)In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 30, 2019
Actual (reported)June 2, 2019
Actual (reported)June 7, 2019
Actual (reported)January 30, 2020
Actual (reported)April 30, 2020
Actual (reported)Overall survival
From date of initial curative surgery for gastric cancer, until the date of death from any cause, up to 60 months
Gastric cancer-specific (disease-free) survival
From date of initial curative surgery for gastric cancer, until the date of diagnosis of gastric cancer recurrence or the date of death, whichever comes first, up to 60 months
Metachronous cancer (remnant stomach cancer)
Up to 60 months
Gastric cancer patients received subtotal gastrectomy, with Helicobacter pylori eradication
Gastric cancer patients received subtotal gastrectomy, without Helicobacter pylori eradication or Helicobacter pylori negative
Antibiotic eradication therapy (triple or quadriple regimen)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients diagnosed with gastric cancer and received surgery (partial, distal, subtotal gastrectomy), and tested Helicobacter pylori status in Seoul National University Bundang Hospital, from 2003 to 2018
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
3,700 participants (actual enrollment reported by the registry).
First Submitted
June 2, 2019
First Posted
June 7, 2019
Study Start
January 30, 2019
Actual (reported)Gastric Cancer Survival Without Chemotherapy
Contact the study team to confirm eligibility.
Primary Completion
January 30, 2020
Actual (reported)Study Completion
April 30, 2020
Actual (reported)Last Updated
November 29, 2024
Record last verified: 2021-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: